In a recent study published in the journal PLOS ONE, researchers in the United States of America (US) investigated the relationship between alcohol use and obesity...
In a review article published in the journal Nature Reviews Cardiology, the authors provide a detailed overview of the global burden of heart failure, including the...
Obesity surgery eclipses weight loss wonder drugs like Wegovy when it comes to saving lives, research shows. The slimming jabs are in short supply due to...
In a recent study published in the New England Journal of Medicine, researchers investigated the effects of tirzepatide on adults with obesity and moderate-to-severe obstructive sleep...
ORLANDO, Fla. — Women with heart failure with preserved ejection fraction (HFpEF) and obesity, with or without diabetes, derive the same benefit from the glucagon-like peptide...
Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that...
Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) — The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care....
According to a recent study by Cancer Mukt Bharat Foundation, a Delhi-based non-profit foundation, 20% of cancer cases in India are now being diagnosed in people...
New research, published in the New England Journal of Medicine, has suggested that the GLP-1 drug Tirzepatide—sold under the brand names Mounjaro and Zepbound for type-2...
ORLANDO, FL — The diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in...
Wegovy (semaglutide) is a sub-cutaneous prescription obesity medicine that has helped people with … [+] obesity. It should be used with a weight loss plan and...
“My weight has always been kind of an issue,” said Gerald Fernandez, a 33-year-old mortgage broker in Naples, Florida. Over the years, he has sought advice...